SHERMAN JEFFREY W — SEC insider filings

SEC reporting owner CIK 1230482. 42 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 42 filings on record, filed 2020-10-21 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Horizon Therapeutics Public Ltd Co (HZNP)EVP and Chief Medical Officer22—14 legs · 292,473 sh · $27,303,25991
Xeris Biopharma Holdings, Inc. (XERS)Director81 leg · 5,400 sh · $10,0981 leg · 42,232 sh · $334,51516
Larimar Therapeutics, Inc. (LRMR)Director62 legs · 8,289 sh · $35,058—4
Strongbridge Biopharma plc (SBBP)Director4——5
XERIS PHARMACEUTICALS INC (XERS)Director2——5

Insider filings — SHERMAN JEFFREY W

FiledFormIssuerReported transactionsSource
2026-11-164Larimar Therapeutics, Inc. (LRMR)Purchase (P): 3,289.47 @ $3.06EDGAR
2026-05-204Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 55,150 (derivative) @ $0EDGAR
2026-03-024Larimar Therapeutics, Inc. (LRMR)Purchase (P): 5,000 @ $5EDGAR
2025-08-294Xeris Biopharma Holdings, Inc. (XERS)Option exercise (M): 47,040 @ $6.66 · Sale (S): 42,232 @ $7.92 · Option exercise (M): 47,040 (derivative) @ $0EDGAR
2025-06-044Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 50,000 @ $0EDGAR
2025-05-144Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-054Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 50,000 @ $0EDGAR
2024-05-314Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-04-114Xeris Biopharma Holdings, Inc. (XERS)Other (J): 6,502EDGAR
2023-11-294Xeris Biopharma Holdings, Inc. (XERS)Purchase (P): 5,400 @ $1.87EDGAR
2023-10-064Horizon Therapeutics Public Ltd Co (HZNP)Disposition to issuer (D): 2,655 @ $116.50 · Disposition to issuer (D): 105,808 @ $116.50 · Disposition to issuer (D): 80,944 @ $116.50 · Disposition to issuer (D): 45,352 @ $116.50 · Disposition to issuer (D): 164,469 (derivative) · Disposition to issuer (D): 9,314 (derivative) · +11 moreEDGAR
2023-10-054Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 16,600 (derivative) @ $0EDGAR
2023-09-074Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 2,165 @ $0EDGAR
2023-06-074Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 42,500 @ $0EDGAR
2023-01-184Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 33,795 @ $0 · Gift (G): 33,795 @ $0EDGAR
2023-01-124Horizon Therapeutics Public Ltd Co (HZNP)Sale (S): 3,368 @ $113.05 · Sale (S): 3,368 @ $113.10EDGAR
2023-01-064Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 51,132 · Tax withholding (F): 22,655 @ $113.24 · Sale (S): 5,187 @ $113.29 · Grant/award (A): 18,397 (derivative) @ $0 · Option exercise (M): 12,095 (derivative) @ $0 · Option exercise (M): 9,314 (derivative) @ $0 · +5 moreEDGAR
2023-01-044Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 21,772 · Tax withholding (F): 9,717 @ $113.80 · Option exercise (M): 21,772 (derivative) @ $0EDGAR
2022-12-294Horizon Therapeutics Public Ltd Co (HZNP)Grant/award (A): 21,772 (derivative) @ $0 · Grant/award (A): 13,972 (derivative) @ $0EDGAR
2022-12-134Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 8,531 @ $0 · Gift (G): 8,531 @ $0 · Sale (S): 6,974 @ $111.44 · Sale (S): 21,378 @ $111.45EDGAR
2022-06-094Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 15,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-04-084Horizon Therapeutics Public Ltd Co (HZNP)Sale (S): 42,009 @ $110.02EDGAR
2022-03-214Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 12,304 @ $0 · Gift (G): 12,304 @ $0 · Gift (G): 5,287 @ $0 · Gift (G): 5,287 @ $0 · Gift (G): 8,169 @ $0 · Gift (G): 8,169 @ $0 · +2 moreEDGAR
2022-01-244Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 5,354 @ $0 · Tax withholding (F): 2,372 @ $86.42 · Option exercise (M): 5,354 (derivative) @ $0EDGAR
2022-01-064Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 10,729 @ $0 · Gift (G): 10,729 @ $0 · Gift (G): 50 @ $0 · Option exercise (M): 52,570 · Grant/award (A): 32,301 @ $0 · Tax withholding (F): 37,675 @ $0 · +6 moreEDGAR
2021-10-294Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 10,729 @ $7.61 · Option exercise (M): 10,729 (derivative) @ $0EDGAR
2021-10-064Strongbridge Biopharma plc (SBBP)Disposition to issuer (D): 64,258 · Disposition to issuer (D): 140,000 (derivative)EDGAR
2021-10-054XERIS PHARMACEUTICALS INC (XERS)Disposition to issuer (D): 19,650 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 11,228 (derivative) · Disposition to issuer (D): 11,228 (derivative)EDGAR
2021-10-054Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 50,378 · Grant/award (A): 47,040 (derivative) · Grant/award (A): 31,360 (derivative) · Grant/award (A): 31,360 (derivative) · Grant/award (A): 19,650 (derivative) · Grant/award (A): 20,000 (derivative) · +2 moreEDGAR
2021-10-054Strongbridge Biopharma plc (SBBP)Tax withholding (F): 17,763 @ $2.06EDGAR
2021-09-234Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 4,042 @ $0 · Gift (G): 4,042 @ $0 · Option exercise (M): 46,271 @ $7.61 · Sale (S): 46,271 @ $110 · Option exercise (M): 46,271 (derivative) @ $0EDGAR
2021-07-304Horizon Therapeutics Public Ltd Co (HZNP)Grant/award (A): 7,257 @ $0 · Tax withholding (F): 3,215 @ $102.50 · Grant/award (A): 14,514 (derivative) @ $0EDGAR
2021-07-024Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 66,730 @ $0 · Gift (G): 66,730 @ $0 · Sale (S): 5,287 @ $95 · Sale (S): 54,789 @ $95.00EDGAR
2021-06-084XERIS PHARMACEUTICALS INC (XERS)Grant/award (A): 11,228 (derivative) @ $0EDGAR
2021-05-184Strongbridge Biopharma plc (SBBP)Grant/award (A): 40,000 @ $0EDGAR
2021-05-174Strongbridge Biopharma plc (SBBP)Tax withholding (F): 18,944 @ $2.35EDGAR
2021-02-194Horizon Therapeutics Public Ltd Co (HZNP)Grant/award (A): 1,965 @ $0 · Tax withholding (F): 871 @ $87.17 · Grant/award (A): 3,931 (derivative) @ $0 · Grant/award (A): 14,512 (derivative) @ $0EDGAR
2021-01-224Horizon Therapeutics Public Ltd Co (HZNP)Gift (G): 8,679 @ $0 · Gift (G): 8,679 @ $0 · Option exercise (M): 5,353 @ $0 · Tax withholding (F): 2,372 @ $77.43 · Option exercise (M): 5,353 (derivative) @ $0EDGAR
2021-01-064Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 41,615 · Grant/award (A): 60,313 @ $0 · Tax withholding (F): 45,256 @ $73.28 · Grant/award (A): 27,942 (derivative) @ $0 · Option exercise (M): 12,261 (derivative) @ $0 · Option exercise (M): 17,260 (derivative) @ $0 · +1 moreEDGAR
2020-12-094Horizon Therapeutics Public Ltd Co (HZNP)Sale (S): 36,389 @ $70.31 · Sale (S): 16,200 @ $71.52 · Sale (S): 10,489 @ $72.24 · Sale (S): 9,631 @ $70.60 · Sale (S): 31,133 @ $71.32EDGAR
2020-10-224/AHorizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 13,000 @ $7.61 · Option exercise (M): 13,000 (derivative) @ $0EDGAR
2020-10-214Horizon Therapeutics Public Ltd Co (HZNP)Option exercise (M): 13,000 @ $7.61 · Option exercise (M): 13,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1230482 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs